LINC01923

Across TCGA pan-cancer cohorts, LINC01923 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01923’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01923 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01923 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.

COAD and READ are the cancer types where LINC01923 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01923 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−0.148	.006	4	view →
READ	All	All	−0.090	.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC01923–COAD

Open the COAD breakdown →